ANA
LOIZAGA IRIARTE
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (4)
2024
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2021
-
Clinical implications of (Pro)renin receptor (prr) expression in renal tumours
Diagnostics, Vol. 11, Núm. 2
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
2020
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2